Back to search

Article

Subtenon Autologous Platelet-Rich Plasma in Degenerative Retinal Diseases: A Prospective Comparative Pilot Study in Retinitis Pigmentosa and Extensive Macular Atrophy with Pseudodrusen-Like Appearance

2026-02-05

Abstract excerpt

<h4>Purpose: </h4> To evaluate the safety, feasibility, and functional outcomes of subtenon autologous platelet-rich plasma (PRP) in patients with retinitis pigmentosa (RP) and Extensive Macular Atrophy with Pseudodrusen-like Appearance (EMAP), two degenerative retinal diseases sharing convergent inflammatory and neurodegenerative pathways. <h4>Methods:</h4> This prospective, comparative pilot study included adult...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fad5df04-1bc3-52d7-b9d9-0b1b25923649
DOI
10.20944/preprints202602.0412.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Subtenon Autologous Platelet-Rich Plasma in Degenerative Retinal Diseases: A Prospective Comparative Pilot Study in Retinitis Pigmentosa and Extensive Macular Atrophy with Pseudodrusen-Like AppearanceDOI 10.20944/preprints202602.0412.v1
Select a neighboring publication to make it the new centre.